MaxCyte, Inc. (MXCT) has a negative trailing P/E of -1.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -57.86%.
Criteria proven by this page:
Overall SharesGrow Score: 48/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -170.3 | -0.85 | 112.08 | 46.44 | - |
| 2017 | -83.4 | -0.83 | 42.20 | 59.13 | - |
| 2018 | -98.1 | 6.54 | 70.85 | 52.21 | - |
| 2019 | -74.4 | -1.81 | 70.49 | 44.34 | - |
| 2020 | -99.9 | 4.00 | 35.54 | 45.13 | - |
| 2021 | -48.4 | -2.18 | 3.51 | 27.24 | - |
| 2022 | -23.6 | 1.73 | 2.19 | 12.55 | - |
| 2023 | -12.8 | -0.14 | 2.09 | 11.76 | - |
| 2024 | -10.6 | -1.97 | 2.11 | 11.29 | - |
| 2025 | -3.7 | -0.48 | 0.96 | 4.99 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-0.10 | $12.27M | $-3.35M | -27.3% |
| 2017 | $-0.20 | $13.99M | $-9.92M | -70.9% |
| 2018 | $-0.17 | $16.67M | $-8.87M | -53.2% |
| 2019 | $-0.24 | $21.62M | $-13.58M | -62.8% |
| 2020 | $-0.18 | $26.17M | $-12.64M | -48.3% |
| 2021 | $-0.22 | $33.89M | $-20.13M | -59.4% |
| 2022 | $-0.19 | $44.26M | $-19.78M | -44.7% |
| 2023 | $-0.37 | $41.29M | $-37.92M | -91.8% |
| 2024 | $-0.39 | $38.63M | $-41.06M | -106.3% |
| 2025 | $-0.42 | $33.03M | $-44.63M | -135.1% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.25 | $-0.25 – $-0.25 | $32.78M | $32.67M – $32.89M | 3 |
| 2027 | $-0.24 | $-0.25 – $-0.23 | $38.8M | $37.46M – $40.14M | 4 |
| 2028 | $-0.20 | $-0.22 – $-0.19 | $47.9M | $47.77M – $48.04M | 3 |
| 2029 | $-0.11 | $-0.12 – $-0.10 | $81.5M | $77.56M – $88.49M | 2 |
